MXPA01009465A - Weight loss after pregnancy. - Google Patents

Weight loss after pregnancy.

Info

Publication number
MXPA01009465A
MXPA01009465A MXPA01009465A MXPA01009465A MXPA01009465A MX PA01009465 A MXPA01009465 A MX PA01009465A MX PA01009465 A MXPA01009465 A MX PA01009465A MX PA01009465 A MXPA01009465 A MX PA01009465A MX PA01009465 A MXPA01009465 A MX PA01009465A
Authority
MX
Mexico
Prior art keywords
pregnancy
weight loss
monohydrate
cyclobutyl
chlorophenyl
Prior art date
Application number
MXPA01009465A
Other languages
Spanish (es)
Inventor
Carl M Mendel
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of MXPA01009465A publication Critical patent/MXPA01009465A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Abstract

A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for aiding weight loss after pregnancy.
MXPA01009465A 1999-03-19 2000-03-17 Weight loss after pregnancy. MXPA01009465A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12514999P 1999-03-19 1999-03-19
PCT/US2000/007202 WO2000056317A1 (en) 1999-03-19 2000-03-17 Weight loss after pregnancy

Publications (1)

Publication Number Publication Date
MXPA01009465A true MXPA01009465A (en) 2004-03-19

Family

ID=22418407

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01009465A MXPA01009465A (en) 1999-03-19 2000-03-17 Weight loss after pregnancy.

Country Status (19)

Country Link
EP (1) EP1162966A4 (en)
JP (1) JP2002539253A (en)
KR (1) KR20010113848A (en)
CN (1) CN1352553A (en)
AU (1) AU4172900A (en)
BG (1) BG105995A (en)
BR (1) BR0009078A (en)
CA (1) CA2367268A1 (en)
CZ (1) CZ20013282A3 (en)
HU (1) HUP0200500A2 (en)
IL (1) IL145243A0 (en)
MX (1) MXPA01009465A (en)
NO (1) NO20014474L (en)
NZ (1) NZ514015A (en)
PL (1) PL351080A1 (en)
SK (1) SK13362001A3 (en)
TR (1) TR200102694T2 (en)
WO (1) WO2000056317A1 (en)
ZA (1) ZA200107680B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
DE19518988A1 (en) * 1995-05-29 1996-12-05 Basf Ag Use of aryl substituted cyclobutylalkylamines to treat obesity

Also Published As

Publication number Publication date
AU4172900A (en) 2000-10-09
SK13362001A3 (en) 2002-07-02
EP1162966A4 (en) 2002-06-12
CZ20013282A3 (en) 2002-07-17
IL145243A0 (en) 2002-06-30
ZA200107680B (en) 2003-06-18
JP2002539253A (en) 2002-11-19
CN1352553A (en) 2002-06-05
NO20014474L (en) 2001-11-14
BG105995A (en) 2002-06-28
WO2000056317A1 (en) 2000-09-28
NO20014474D0 (en) 2001-09-14
HUP0200500A2 (en) 2002-08-28
PL351080A1 (en) 2003-03-10
NZ514015A (en) 2001-09-28
BR0009078A (en) 2001-12-26
KR20010113848A (en) 2001-12-28
CA2367268A1 (en) 2000-09-28
TR200102694T2 (en) 2002-04-22
EP1162966A1 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
CA2367666A1 (en) Method of treating eating disorders
EP0814788A4 (en) Improving glucose tolerance
DK0973511T3 (en) Use of sibutramine analogues to lower lipid levels
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
WO2000056315A8 (en) Treatment of pain
IL128851A (en) Pharmaceutical composition for lowering the uric acid level in the human body
MXPA01009469A (en) Treatment to lower platelet adhesiveness.
MXPA01009465A (en) Weight loss after pregnancy.
TWI255813B (en) Compounds for use as alphavbeta3 receptor antagonists
BG105999A (en) Treatment of osteoarthritis
MXPA01009468A (en) Treatment of pulmonary hypertension.
MXPA01009463A (en) Treatment of hiatial hernia.
MXPA01009462A (en) Treatment of gallstones.
BG105998A (en) Treatment of certain cancers associated with weight gain
BG105996A (en) Method of treating eating disorders
MXPA02003516A (en) Polymorphic n [3 [[2 (3,4 dimethoxyphenyl) ethyl] amino] propyl] 4 nitro benzamide hydrochloride.